Home  Feedback  Career  Sitemap  Contact Us
 
Market Buzz
Corporate Info
Market Analysis
Movers
Corporate Action
Other Markets
IPO
 
Divis Laboratories Ltd
  Divis Laboratories Ltd - Statement Of Investor Complaints For The Quarter Ended June 2018 | [05-Jul-2018]
  Divis Laboratories Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication | [04-Jul-2018]
  Divis Laboratories Ltd - Divis Laboratories Limited - Updates | [04-Jul-2018]
  Divis Laboratories Ltd spurts nearly 3% | [03-Jul-2018]
  Divis Laboratories Ltd slips for fifth straight session | [22-Jun-2018]
  Divis Laboratories Ltd slips for fifth straight session | [01-Jun-2018]
  Divi's Laboratories standalone net profit rises 0.89% in the March 2018 quarter | [28-May-2018]
  Divis Laboratories Ltd - Divis Laboratories Limited - Auditors report | [28-May-2018]
  Board of Divis Laboratories recommends Final Dividend | [26-May-2018]
  Divis Laboratories Ltd - Audited Standalone And Consolidated Financial Results For The Year Ended 31St March, 2018 | [26-May-2018]
  Divis Laboratories Ltd - Board recommends Dividend | [26-May-2018]
  Divis Laboratories Ltd - Audit Report On Audited Financial Results For The Year Ended 31St March 2018 As Per Regulation 33(3)(D) Of The SEBI (LODR) Regulations, 2015 | [26-May-2018]
  Divi's Labs rises after successful USFDA inspection of Telangana unit | [17-May-2018]
  Divis Laboratories Ltd - Divis Laboratories Limited - Updates | [17-May-2018]
  Divis Laboratories Ltd - Board Meeting On 26/05/2018 | [16-May-2018]
Back Top
Source:Capital Market

Member Code : NCDEX - 00241 | MCX - 31435
SEBI Regn. Nos : BSE INB010643030 | NSE(EQ) INB230643037 | NSE(FUT) INF230643037 FOR INVESTORS GRIEVANCE : complaints@cilsecurities.com
FOR DP GRIEVANCE : grievance@cilsecurities.com
Privacy Policy  |  Disclaimer | BrokerNorms |  BSE Complaints
Useful Links :  NSE | BSE  | CDSL | MCX  | NCDEX | SEBI | RBI
Designed , Developed & Powered By C-MOTS Infotech
(ISO 9001:2015 certified)